Moreover, we showed that the activity of the PI3K–AKT–mTOR pathway, as measured by the phosphorylation of ribosomal protein S6, further increased in MM-Act-MSCs upon contact with MM cells, whereas CTR-MSCs showed no effect and MM-Rm-MSCs even responded with a downregulation. The gene discussed is RPS6; the disease is Miyoshi myopathy.